SearcharxivSearch

arXiv subjects

David M. Routman

Publications and source records attributed to David M. Routman.

5 recordsLinked to original sources

Morphology signal in whole slide image foundation models can automatically triage slides

Patient exams in the cancer diagnosis and staging process typically generate several whole slide images (WSIs). One of the initial steps in training models on WSI data is identifying one or a few slides containing tumor or other diagnostic biomarkers necessary for downstream prediction tasks such as estimating recurrence risk or progression-free survival. This step requires tedious manual curation by experienced pathologists. Many published datasets make the artificial assumption of 1 slide per patient. Alternatively, all slides per patient may be used for model training, which may dilute the signal from the few slides containing tumor or other relevant information. In this paper, we present a pipeline to overcome these challenges using publicly available WSI foundation models (FMs). Our evaluations show that ranking WSIs based on predictions from zero-shot classification using WSI FMs accurately identifies slides with the most tumor, indicating that WSI FMs contain sufficient morphology signal to automatically triage slides. We also present a formulation for ranked evaluation to benchmark FM performance in slide triage. We show, on multiple datasets, that tumor slides are identified in the top-2 ranked slides for patients with up to 43 slides.

cs.CV

The Cost of Binarizing Survival Outcomes in Clinical Prognostic Modeling

Survival analysis is an established framework for analyzing time-to-event data, yet many clinical machine learning studies still binarize the outcome before model training. This practice excludes censored patients, collapses temporal information into a single threshold, and can affect which features are selected as prognostically relevant. We examine the cost of this binarization in the context of Bayesian network (BN) feature selection, using two recent publications as case studies: one that applies BN-based feature selection to a head-and-neck cancer cohort and a second surgical cohort study that, while not BN-based, likewise binarizes its survival endpoint. We replace the binary scoring function with the Cox partial log-likelihood for feature-to-outcome edges, a modification we call the Survival-Aware Bayesian network, and recover prognostic features that binarization misses. Our ablation experiment confirms that the improvement is driven by the time-to-event scoring formulation rather than by retaining more patients. The results generalize across five endpoint-cohort combinations in head-and-neck cancer and extend to three further cancer types (breast, colorectal, and kidney). We propose that clinical studies with survival outcomes should use time-to-event methods by default, as binarization discards the prognostic signal retained by survival analysis.

q-bio.QM

A Two-Stage Framework for Fast Proton Spot Map Generation in Pencil Beam Scanning Prostate SBRT Planning

Background: In pencil beam scanning (PBS) proton therapy, plans are delivered as proton spot maps (PSMs). Although deep learning can rapidly predict 3D dose, direct conversion of dose into deliverable spot patterns remains limited. Purpose: We developed GenSpot, a two stage framework that infers deliverable PSMs from CT and dose, and evaluated it in prostate SBRT by comparing Monte Carlo (MC) doses from GenSpot and clinical PSMs. Methods: GenSpot uses a physics informed projected proton spot map (PrPSM) representation, projecting spots through CT with water equivalent thickness and PDD information to align spots with the CT/dose grid while preserving linearity with spot weights. The dataset included 1,036 fields from 259 prostate SBRT plans, split 80%/10%/10% for training, validation, and testing. A 3D SwinUNETR predicted PrPSMs from CT and dose. Field specific PSMs were reconstructed using column wise nonnegative Lasso regression with precomputed PDD curves. GenSpot and clinical MC doses were compared using MAE, 3D gamma analysis, and composite plan DVH metrics. Results: On the test set, SwinUNETR achieved PrPSM MAE of 0.06 +/- 0.02 with high similarity to clinical PrPSMs. GenSpot MC doses showed low MAE of 0.07 +/- 0.03 Gy in the nonzero dose region and gamma passing rates of 0.90 at the field level and 0.97 at plan level. Composite DVH differences were within 1 Gy for targets and organs at risk, though the CTV showed a modest high dose increase. Spot complexity was similar to clinical plans, with slightly more spots. Prediction and reconstruction averaged 0.02 s and 2.1 s/field. Conclusions: GenSpot generated machine deliverable PSMs from CT and dose whose MC doses closely matched clinical PSM doses in a single institution prostate SBRT cohort. This physics informed dose to spots framework may support automated PBS planning and adaptive replanning, pending broader validation.

physics.med-ph

The Daily Dose: Workflow-Integrated Large Language Model Automation for Clinical Summarization and Trial Identification in Radiation Oncology

Objective: To describe the design and early clinical evaluation of The Daily Dose (TDD), an LLM-driven, automated clinical summarization and clinical-trial identification system integrated into routine radiation oncology practice. Design: Mixed-methods evaluation using a cross-sectional, anonymous clinician survey administered after 1 month of system deployment. Exposure: Daily automated delivery of physician-specific email summaries generated using RadOnc-GPT, including patient schedules, concise EHR-derived clinical-status summaries, and automated identification of potentially relevant clinical trials for new or consult visits. Main Outcomes and Measures: Primary outcomes included self-reported usability, satisfaction, perceived usefulness, perceived impact on workflow, time savings, and intention for continued use. Internal consistency reliability was assessed using Cronbach's $α$. Results: Among 55 respondents, 52 (94.5\%) worked in radiation oncology, and 38 (69.1\%) were attending physicians. Most participants (83.6\%) reported using TDD daily or several times per week. Mean (SD) scores were 3.89 (1.04) for usability and satisfaction, 3.43 (1.24) for perceived usefulness, and 3.80 (1.17) for impact and future use (5-point Likert scale). Overall satisfaction was positively associated with perceived time savings ($p < .001$). Participants reported variable time savings, with 27\% estimating $\geq 10$ minutes saved per day. The questionnaire demonstrated excellent internal consistency (overall Cronbach's $α$ = 0.97).

cs.CL

Retrospective Comparative Analysis of Prostate Cancer In-Basket Messages: Responses from Closed-Domain LLM vs. Clinical Teams

In-basket message interactions play a crucial role in physician-patient communication, occurring during all phases (pre-, during, and post) of a patient's care journey. However, responding to these patients' inquiries has become a significant burden on healthcare workflows, consuming considerable time for clinical care teams. To address this, we introduce RadOnc-GPT, a specialized Large Language Model (LLM) powered by GPT-4 that has been designed with a focus on radiotherapeutic treatment of prostate cancer with advanced prompt engineering, and specifically designed to assist in generating responses. We integrated RadOnc-GPT with patient electronic health records (EHR) from both the hospital-wide EHR database and an internal, radiation-oncology-specific database. RadOnc-GPT was evaluated on 158 previously recorded in-basket message interactions. Quantitative natural language processing (NLP) analysis and two grading studies with clinicians and nurses were used to assess RadOnc-GPT's responses. Our findings indicate that RadOnc-GPT slightly outperformed the clinical care team in "Clarity" and "Empathy," while achieving comparable scores in "Completeness" and "Correctness." RadOnc-GPT is estimated to save 5.2 minutes per message for nurses and 2.4 minutes for clinicians, from reading the inquiry to sending the response. Employing RadOnc-GPT for in-basket message draft generation has the potential to alleviate the workload of clinical care teams and reduce healthcare costs by producing high-quality, timely responses.

cs.AI